US Edition
Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Enzybel Pharma 2 and Deebio partner to address pancrelipase shortages - Pharmafile
Enzybel Pharma 2, part of European distributor Natix, has formed an alliance with Chinese enzyme manufacturer Deebio to help alleviate the global shortage of high-activity pancrelipase (pancreatin). The partnership will focus on producing a highly purified, standardised form of the active pharmaceutical ingredient (API), used in the treatment of pancreatic insufficiency. To meet European and […] The post Enzybel Pharma 2 and Deebio partner to ad…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
